Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
View ORCID ProfileErik Jue, View ORCID ProfileRustem F. Ismagilov
doi: https://doi.org/10.1101/2020.04.28.20077602
Erik Jue
aDivision of Biology and Biological Engineering
Rustem F. Ismagilov
aDivision of Biology and Biological Engineering
bDivision of Chemistry and Chemical Engineering
Data Availability
All data will be made available at CaltechDATA upon publication.
Posted May 04, 2020.
Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
Erik Jue, Rustem F. Ismagilov
medRxiv 2020.04.28.20077602; doi: https://doi.org/10.1101/2020.04.28.20077602
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6720)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)